Thermo Fisher Scientific Inc. (TMO)
NYSE: TMO · Real-Time Price · USD
475.66
-6.38 (-1.32%)
At close: Jun 11, 2026, 4:00 PM EDT
470.12
-5.54 (-1.16%)
After-hours: Jun 11, 2026, 7:35 PM EDT

Thermo Fisher Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
176,765218,002198,090205,229214,217263,079
Market Cap Growth
16.04%10.05%-3.48%-4.20%-18.57%42.39%
Enterprise Value
216,670247,411223,882232,173240,351293,656
Last Close Price
475.66579.45520.23530.79550.69667.24
PE Ratio
26.1532.6631.4734.3631.2434.29
Forward PE
18.7424.0522.8724.6525.0032.55
PEG Ratio
2.183.132.762.511.171.91
PS Ratio
3.914.894.624.794.776.71
PB Ratio
3.404.084.004.394.876.45
P/TBV Ratio
3.454.104.024.414.936.49
P/FCF Ratio
26.2034.6427.2629.6331.0038.75
P/OCF Ratio
21.3327.8822.8624.4123.4028.25
EV/Sales Ratio
4.795.555.225.425.357.49
EV/EBITDA Ratio
19.1823.5021.4322.6220.4123.27
EV/EBIT Ratio
25.5331.9430.5133.8528.6429.28
EV/FCF Ratio
32.1139.3230.8133.5234.7843.25
Debt / Equity Ratio
0.830.740.630.750.780.85
Debt / EBITDA Ratio
4.033.742.993.402.932.76
Debt / FCF Ratio
6.406.264.305.044.995.14
Net Debt / Equity Ratio
0.770.550.520.570.590.75
Net Debt / EBITDA Ratio
3.732.782.462.612.212.41
Net Debt / FCF Ratio
5.914.653.543.873.764.48
Asset Turnover
0.400.430.440.440.470.48
Inventory Turnover
1.315.065.004.804.864.31
Quick Ratio
0.851.251.031.160.980.93
Current Ratio
1.531.891.661.751.481.50
Return on Equity (ROE)
13.07%13.10%13.22%13.22%16.76%20.48%
Return on Assets (ROA)
6.56%6.90%6.79%6.69%7.95%10.68%
Return on Invested Capital (ROIC)
7.62%8.20%7.99%8.03%9.40%13.02%
Return on Capital Employed (ROCE)
8.14%8.65%8.70%8.32%10.37%14.28%
Earnings Yield
3.87%3.06%3.18%2.91%3.20%2.92%
FCF Yield
3.82%2.89%3.67%3.38%3.23%2.58%
Dividend Yield
0.39%0.29%0.29%0.26%0.21%0.15%
Payout Ratio
9.89%9.49%9.20%8.72%6.55%5.11%
Buyback Yield / Dilution
1.38%1.31%1.29%1.52%0.76%0.50%
Total Shareholder Return
1.76%1.60%1.58%1.78%0.97%0.65%
SEC Filings: 10-K · 10-Q